Individual- and provider-level factors associated with colorectal cancer screening in accordance with guideline recommendation: A community-level perspective across varying levels of risk

BMC Public Health

Volumn 13, Issue 1, 2013, Pages

  Courtney, Ryan J ^a,d,e   Paul, Christine L ^a,d   Sanson Fisher, Robert W ^a,d   Macrae, Finlay A ^b   Carey, Mariko L ^a,d   Attia, John ^c,d   McEvoy, Mark ^c,d  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

^c UNIVERSITY OF NEWCASTLE   (Australia)

^d HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; AUSTRALIA; COLORECTAL TUMOR; DOCTOR PATIENT RELATION; EARLY DIAGNOSIS; GENETIC PREDISPOSITION; GENETICS; HUMAN; MIDDLE AGED; PATIENT COMPLIANCE; PRACTICE GUIDELINE; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SOCIOECONOMICS; STANDARD; STATISTICS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AUSTRALIA; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; GENETIC PREDISPOSITION TO DISEASE; GUIDELINE ADHERENCE; HUMANS; MIDDLE AGED; PATIENT COMPLIANCE; PHYSICIAN-PATIENT RELATIONS; PRACTICE GUIDELINES AS TOPIC; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; SOCIOECONOMIC FACTORS;

MLCS; MLOWN;

EID: 84875067958     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-13-248     Document Type: Article

References (68)

1. World Health Organisation, International Agency for Research on Cancer. GLOBOCAN. Cancer incidence and mortality worldwide in 2008 http://globocan.iarc. fr/
2. National Cancer Institute Surveillance Epidemiology and End Results, SEER Stats Facts Sheets. Colon and rectum cancer survival and stage http://seer.cancer.gov/statfacts/html/colorect.html
3. The effect of fecal occult-blood screening on the incidence of colorectal cancer. Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, Snover DC, Schuman LM, N Engl J Med 2000 343 1603 1607 10.1056/NEJM200011303432203 11096167 (Pubitemid 32162983)
4. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, Sternberg SS, Waye JD, Schapiro M, Bond JH, Panish JF, N Engl J Med 1993 329 1977 1981 10.1056/NEJM199312303292701 8247072 (Pubitemid 24015040)
5. Initial impact of Australia's National Bowel Cancer Screening Program. Ananda SS, McLaughlin SJ, Chen F, Hayes IP, Hunter AA, Skinner IJ, Steel MCA, Jones IT, Hastie IA, Rieger NA, Shedda S, Compston DJ, Gibbs P, Med J Aust 2009 191 378 381 19807627
6. Randomised controlled trial of fecal occult blood screening for colorectal cancer. Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, James PD, Mangham CM, Lancet 1996 348 1472 1477 10.1016/S0140-6736(96)03386-7 8942775 (Pubitemid 26400242)
7. Australian Cancer Network Colorectal Cancer Guidelines Revision Committee, Clinical Practice Guidelines for the Prevention, Early Detection and Management of Colorectal Cancer http://www.nhmrc.gov.au/-files-nhmrc/ publications/attachments/cp106-0.pdf
8. National Bowel Cancer Screening Program-information for the public http://www.medicareaustralia.gov.au/public/services/nbcsp/index.jsp
9. Australian Institute of Health & Welfare & Australian Government Department of Health Ageing, National Bowel Cancer Screening Program: annual monitoring report 2009 data and data supplement 2010 Canberra: AIHW 2010 Cancer Series no.57. Cat. No. CAN 53
10. Costs and cost-effectiveness of full implementation of a biennial faecal occult blood test screening program for bowel cancer in Australia. Pignone M, Flitcroft KL, Howard K, Trevana LJ, Salkeld GP, St John J, Med J Aust 2010 194 180 185
11. Australian Institute of Health & Welfare & Australian Government Department of Health Ageing, National Bowel Cancer Screening Program: annual monitoring report 2009 Canberra: AIHW 2009 Cancer series no. 49. Cat. no. CAN 45
12. Australian Institute of Health & Welfare & Australian Government Department of Health Ageing, National Bowel Cancer Screening Program monitoring report 2007 Canberra: AIHW 2008 Cancer series no. 40. Cat. no. CAN 35
13. Australian Institute of Health & Welfare & Australian Government Department of Health Ageing, National Bowel Cancer Screening Program monitoring report 2008 Canberra: AIHW 2008 Cancer series 44. Cat. no. 40
14. The UK colorectal cancer screening pilot: results of the second round of screening in England. Weller D, Coleman D, Robertson R, Butler P, Melia J, Campbell C, Parker R, Patnick J, Moss S, Br J Cancer 2007 97 1601 1605 10.1038/sj.bjc.6604089 18026197 (Pubitemid 350249359)
15. Test, episode, and programme sensitivities of screening for colorectal cancer as a public health policy in Finland: experimental design. Malila N, Oivanen T, Malminiemi O, Hakama M, BMJ 2008 337 3371 3375
16. Screening for bowel cancer among NSW adults with varying levels of risk: a community survey. Cockburn J, Paul C, Tzelepis F, McElduff P, Byles J, Aust N Z J Public Health 2002 26 236 241 10.1111/j.1467-842X.2002.tb00680.x 12141619 (Pubitemid 35446372)
17. Colorectal cancer: a survey of community beliefs and behaviours in Victoria. Thomas RJ, Clarke VA, Med J Aust 1998 169 37 40 9695701 (Pubitemid 28330458)
18. Colorectal cancer and its prevention: prevalence of beliefs, attitudes, intentions and behaviour. Weller DP, Owen N, Hiller JE, Willson K, Wilson D, Aust J Public Health 1995 19 19 23 7734587
19. Population characteristics related to colorectal cancer testing in New South Wales, Australia: results from the 45 and Up Study cohort. Weber MF, Banks E, Ward R, Sitas F, J Med Screen 2008 15 137 142 10.1258/jms.2008.008050 18927096
20. Colorectal cancer screening barriers and facilitators in older persons. Guessous I, Dash C, Lapin P, Doroshenk M, Smith RA, Klabunde CN, Prev Med 2010 50 3 10 10.1016/j.ypmed.2009.12.005 20006644
21. Socioeconomic variation in participation in colorectal cancer screening. McCaffery K, Wardle J, Nadel M, Atkin W, J Med Screen 2002 9 104 108 10.1136/jms.9.3.104 12370320 (Pubitemid 35205231)
22. Screening particpation in individuals with a family history of colorectal cancer: a review. Rees G, Martin PR, Macrae FA, Eur J Cancer Care 2007 17 221 232
23. Patterns and predictors of colorectal cancer test use in the adult U.S. population. Seeff LC, Nadel MR, Klabunde CN, Thompson T, Shapiro JA, Vernon SW, Coates RJ, Cancer 2004 100 2093 2103 10.1002/cncr.20276 15139050 (Pubitemid 38580326)
24. Adherence with colorectal cancer guidelines: a review. Subramanian S, Klosterman BA, Amonkar MM, Hunt TL, Prev Med 2004 38 536 540 10.1016/j.ypmed.2003.12.011 15066356 (Pubitemid 38452879)
25. Gender difference in utilization of colorectal cancer screening. Wardle J, Miles A, Atkin W, J Med Screen 2005 12 20 27 10.1258/0969141053279158 15814015 (Pubitemid 40445072)
26. Healthcare system factors and colorectal cancer screening. Zapka JG, Puleo E, Vickers-Lahti M, Luckmann R, Am J Prev Med 2002 23 28 35 10.1016/S0749-3797(02)00444-0 12093420 (Pubitemid 34687129)
27. Demographic associations with stage of readiness to screen for colorectal cancer. Duncan A, Wilson C, Cole SR, Mikocka-Walus A, Turnbull D, Young GP, Health Promotion Journal of Australia 2009 20 7 12 19402809
28. Knowledge, perception and practices of colorectal cancer screening in an ethnically diverse population. Koo JH, Arasaratnam MM, Liu K, Redmond DM, Connor SJ, Sung JJY, Leong RWL, Cancer Epidemiol 2010 34 604 610 10.1016/j.canep.2010. 05.013 20580631
29. Dillman DA, Mail and Telephone Surveys: The Total Design Method New York: John Wiley & Sons 1978
30. Cohort profile: The Hunter Community Study. McEvoy M, Smith W, D'Este C, Duke J, Peel R, Schofield P, Scott R, Byles J, Henry D, Ewald B, Hancock S, Smith D, Attia J, Int J Epidemiol 2010 39 1452 1463 10.1093/ije/dyp343 20056765
31. Current state of medical-advice-seeking behaviour for symptoms of colorectal cancer: determinants of failure and delay in medical consultation. Courtney RJ, Paul CL, Sanson-Fisher RW, Macrae F, Attia J, McEvoy M, Col Dis 2012 14 222 229 10.1111/j.1463-1318.2012.02881.x
32. Factors associated with consultation behaviour for primary symptoms potentially indicating colorectal cancer: A cross-sectional study on response to symptoms. Courtney RJ, Paul CL, Sanson-Fisher RW, Macrae FA, Attia J, McEvoy M, BMC Gastroenterol 2012 12 100 10.1186/1471-230X-12-100 22862960
33. Participation in screening for colorectal cancer based on a faecal occult blood test is improved by endorsement by the primary care practitioner. Cole SR, Young GP, Byrne D, Guy JR, Morcom J, J Med Screen 2002 9 147 152 10.1136/jms.9.4.147 12518003 (Pubitemid 36135339)
34. Endorsement by the primary care practitioner consistently improves participation in screening for colorectal cancer: a longitudinal analysis. Zajac IT, Whibley AH, Cole SR, Byrne D, Guy J, Morcom J, Young GP, J Med Screen 2010 17 19 24 10.1258/jms.2010.009101 20356941
35. Interventions that increase the use of adult immunization and cancer screening services: a meta-analysis. Stone EG, Morton SC, Hulscher ME, Maglione MA, Roth EA, Grimshaw JM, Mittman BS, Rubenstein LV, Shekelle PG, Ann Intern Med 2002 136 641 651 11992299 (Pubitemid 34462676)
36. Direct observation of counselling on colorectal cancer in rural primary care practices. Ellerbeck EF, Engelman KK, Gladden J, Mosier MC, Raju GS, Ahluwalia JS, J Gen Intern Med 2001 16 697 700 10.1111/j.1525-1497.2001.01224.x 11679038 (Pubitemid 32964851)
37. Health plan policies and programs for colorectal cancer screening: a national profile. Klabunde CN, Riley GF, Mandelson MT, Frame PS, Brown ML, Am J Manag Care 2004 10 273 279 15124504 (Pubitemid 38480797)
38. In search of a familial cancer risk assessment tool. Kelly KM, Sweet K, Clin Genet 2007 71 76 83 17204050 (Pubitemid 44921624)
39. Efficacy of touchscreen computer based family cancer history questionnaire and subsequent cancer risk assessment. Westman J, Hampel H, Bradley T, J Med Genet 2000 37 354 360 10.1136/jmg.37.5.354 10807694 (Pubitemid 30261267)
40. Predictors of colorectal cancer screening participation in the United States. Ioannou GN, Chapko MK, Dominitz JA, Am J Gastroenterol 2003 98 2082 2091 10.1111/j.1572-0241.2003.07574.x 14499792 (Pubitemid 37185810)
41. Colorectal cancer screening in Canada: Results of a national survey. Sewitch MJ, Fournier C, Ciampi A, Dyachenko A, Chronic Dis Can 2008 29 9 21 19036219
42. How equitable are colorectal cancer screening programs which include FOBTs? A review of the qualitative and quantitiative studies. Javanparast S, Ward P, Young G, Wilson C, Carter S, Misan G, Cole S, Jiwa M, Tsourtos G, Martini A, Gill T, Baratiny G, Matt MA, Prev Med 2010 50 165 172 10.1016/j.ypmed.2010.02.003 20153359
43. Adherence to continuous screening for colorectal neoplasia. Myers RE, Balshem AM, Wolf TA, Ross EA, Millner L, Med Care 1993 31 508 519 10.1097/00005650-199306000-00004 8501998
44. Patient preferences for colon cancer screening. Pignone M, Bucholtz D, Harris R, J Gen Intern Med 1999 14 432 437 10.1046/j.1525-1497.1999.00018.x 10417601 (Pubitemid 29344619)
45. Equity of colorectal cancer screening: a cross-sectional anlaysis of National Bowel Cancer Screening Program data for South Australia. Ward PR, Javanparast S, Ah Matt M, Martini A, Tsourtos G, Aust N Z J Public Health 2010 35 61 65 21299702
46. Inequalities in colorectal cancer screening participation in the first round of the national screening programme in England. von Wagner C, Good A, Wright D, Rachet B, Obichere A, Bloom S, Wardle J, Br J Cancer 2009 101 60 63
47. Association of socioeconomic status and receipt of colorectal cancer investigations: a population-based retrospective cohort study. Singh SM, Paszat LF, Li C, He J, Vinden C, Rabeneck L, CMAJ 2004 171 461 465 10.1503/cmaj.1031921 15337726 (Pubitemid 39179607)
48. Trends in colorectal cancer test use in the medicare population, 1998-2005. Schenck AP, Peacock SC, Klabunde CN, Lapin P, Coan JF, Brown ML, Am J Prev Med 2009 37 1 7 10.1016/j.amepre.2009.03.009 19423273
49. Disparities despite coverage. Gaps in colorectal cancer screening among medicare beneficiaries. O'Malley AS, Forrest CB, Feng S, Mandelblatt J, Arch Intern Med 2005 165 2129 2135 10.1001/archinte.165.18.2129 16217003 (Pubitemid 41434589)
50. Dixon A, Legrand J, Henderson J, Murray R, Poteliakhoff E, Is the NHS equitable? A review of evidence http://www.erpho.org.uk/viewResource.aspx?id= 8772
51. Ulin PR, Robinson ET, Tolley EE, Qualititative methods in public health San Francisco, CA: Jossey-Boss 2005
52. Fishbein M, Developing effective behavior change interventions: some lessons learned from behavioral research Rockville, MD: National Institutes of Health 1995
53. Colorectal cancer screening behavior and health insurance status. Matthews BA, Anderson RC, Nattinger AB, Cancer Cause Control 2005 16 735 742 10.1007/s10552-005-1228-z (Pubitemid 41110964)
54. Validity of self-reported colorectal cancer screening behavior. Baier M, Calonge N, Cutter G, McClatchey M, Schoentgen S, Hines S, Marcus A, Ahnen D, Cancer Epidemiol Biomarkers Prev 2000 9 229 232 10698488 (Pubitemid 30111950)
55. Validation of self-reported history of colorectal cancer screening. Khoja S, McGregor ES, Hilsden RJ, Can Fam Physician 2007 53 1192 1197 17872816 (Pubitemid 47236005)
56. Accuracy of self-reported cancer-screening histories: a meta-analysis. Rauscher GH, Johnson TP, Cho YL, Walk JA, Cancer Epidemiol Biomarkers Prev 2008 17 748 757 10.1158/1055-9965.EPI-07-2629 18381468 (Pubitemid 351536402)
57. Validation of self-reported colorectal cancer screening behaviour from a mixed-mode survey of veterans. Partin MR, Grill J, Noorbaloochi S, Powell A, Burgess DJ, Vernon SW, Halek K, Griffin JM, van Ryn M, Fisher DA, Cancer Epidemiol Biomarkers Prev 2008 17 768 776 10.1158/1055-9965.EPI-07-0759 18381474 (Pubitemid 351536404)
58. Validity of four self-reported colorectal cancer screening modalities in a general population: differences over time and by intervention assignment. Jones RM, Mongin SJ, Lazovich D, Church TR, Yeazel MW, Cancer Epidemiol Biomarkers Prev 2008 17 777 784 10.1158/1055-9965.EPI-07-0441 18381476 (Pubitemid 351536405)
59. Validation of family history data in cancer family registries. Ziogas A, Anton-Culver H, Am J Prev Med 2003 24 190 198 10.1016/S0749-3797(02)00593-7 12568826 (Pubitemid 36144098)
60. Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history. Murff HJ, Spigel DR, Syngal S, JAMA 2004 292 1480 1489 10.1001/jama.292.12.1480 15383520 (Pubitemid 39258342)
61. Accuracy of family history of colorectal cancer. Mitchell RJ, Brewster D, Campbell H, Porteous MEM, Wyllie AH, Bird CC, Dunlop G, Gut 2008 53 291 295
62. Why do we still use stepwise modelling in ecology and behaviour? Whittingham MJ, Stephens PA, Bradbury RB, Freckelton RP, J Anim Ecol 2006 75 1182 1189 10.1111/j.1365-2656.2006.01141.x 16922854 (Pubitemid 44175184)
63. Comparison of logistic regression versus propensity score when the number of events is low and there a multiple confounders. Soledad Cepeda M, Boston R, Farrar JT, Strom BL, Am Epidemiol 2003 158 280 287 10.1093/aje/kwg115 (Pubitemid 36944422)
64. Bias in error rate estimates in discriminant analysis when stepwise variable selection is employed. Rutter C, Virgina F, Lachenbruch P, Commun Stat Simulat 1991 20 1 22 10.1080/03610919108812935
65. Backward, forward and stepwise automated subset selection algoritms: Frequency of obtaining authentic and noise variables. Derksen S, Keselman HJ, Brit J Math Stat Psy 1992 45 265 282 10.1111/j.2044-8317.1992.tb00992.x
66. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota colon cancer control study. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, Ederer F, N Engl J Med 1993 328 1365 1371 10.1056/NEJM199305133281901 8474513 (Pubitemid 23131388)
67. Randomised study of screening for colorectal cancer with faecal occult blood test. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O, Lancet 1996 348 1467 1471 10.1016/S0140-6736(96)03430-7 8942774 (Pubitemid 26400241)
68. Cancer Council Australia, Cancer Council Australia pre-budget submission, 2011-12. Bowel cancer screening: program expansion would reduce Medicare and PBS costs-and save lives http://www.cancer.org.au/policy/ submissionstogovernment/Cancer-Council-Australia-pre-budget-submission-2011- 2012.htm